gallium-ga-68-dotatate and Prostatic-Hyperplasia

gallium-ga-68-dotatate has been researched along with Prostatic-Hyperplasia* in 1 studies

Other Studies

1 other study(ies) available for gallium-ga-68-dotatate and Prostatic-Hyperplasia

Article	Year
68Ga-DOTATATE in Benign Prostate Hyperplasia. Clinical nuclear medicine, 2019, Volume: 44, Issue:3 A 79-year-old man had carcinoid syndrome and bilateral pulmonary nodules, which were biopsy confirmed as well-differentiated neuroendocrine tumor. PET/CT with Ga-[DOTA-Tyr]-octreotate (Ga-DOTATATE) showed multiple Ga-DOTATATE-avid bilateral pulmonary nodules, left hilar lymph node, as well as diffuse increased Ga-DOTATATE uptake in the prostate. A review of the history revealed that this patient had elevated prostate-specific antigen level. The prostate biopsy did not reveal evidence of prostate cancer but showed benign prostate hyperplasia. Topics: Aged; Humans; Male; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Hyperplasia; Radiopharmaceuticals	2019

Article

Year

68Ga-DOTATATE in Benign Prostate Hyperplasia.

Clinical nuclear medicine, 2019, Volume: 44, Issue:3

A 79-year-old man had carcinoid syndrome and bilateral pulmonary nodules, which were biopsy confirmed as well-differentiated neuroendocrine tumor. PET/CT with Ga-[DOTA-Tyr]-octreotate (Ga-DOTATATE) showed multiple Ga-DOTATATE-avid bilateral pulmonary nodules, left hilar lymph node, as well as diffuse increased Ga-DOTATATE uptake in the prostate. A review of the history revealed that this patient had elevated prostate-specific antigen level. The prostate biopsy did not reveal evidence of prostate cancer but showed benign prostate hyperplasia.

Topics: Aged; Humans; Male; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Hyperplasia; Radiopharmaceuticals

2019